Neoplasms
Hematology
Oncology Nursing
Radiation Oncology
Clinical Trials as Topic
Antineoplastic Combined Chemotherapy Protocols
Italy
Oncology Service, Hospital
Chemotherapy, Adjuvant
Retrospective Studies
Treatment Outcome
Survival Rate
Questionnaires
Neoplasm Staging
United States
Prognosis
Drug development in solid tumors: personal perspective of Dr. Emil J Freireich's contributions. (1/1614)
The development of chemotherapy for patients with the major cancers progressed from the initial success attained in the treatment of acute leukemias and choriocarcinoma. Many of the principles of therapy were based on the concepts developed in the experimental laboratories and early clinical studies done at the NIH Clinical Center and other centers around the country. The purpose of this review is to describe some of the early advances in cancer therapy and show how many are based on the efforts of Dr. Emil J Freireich. Over his career, Dr. Freireich has published more than 500 papers and worked on more than 70 different drugs and combinations. The principles defined by Dr. Freireich, namely, the use of intermittent intensive chemotherapy to induce complete remissions (CRs), intensification of therapy in remission, and the use of unmaintained remissions to assess cure, have been important in developing curative chemotherapy programs in patients with acute leukemias. These same principles were applied to combination therapy of Hodgkin's disease as the nitrogen mustard, vincristine, procarbazine, and prednisone combination was developed. This led to the high CR and cure rate for this disease. The treatment of metastatic breast cancer does not produce a high proportion of CRs, and cures of metastatic disease are unlikely with chemotherapy alone. But adjuvant chemotherapy after surgery has resulted in a significant reduction in cancer mortality. Many challenges remain in increasing the cure rate for the major solid tumors. New avenues of controlling cell growth and metastases need to be explored. One approach that is exploitable is the use of drugs or nutrients to prevent cancer. Laboratory approaches are now becoming a clinical reality. (+info)Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award Lecture. (2/1614)
The purpose of this study was to review the progress in clinical and translational research in chronic myelogenous leukemia (CML) over the past 20 years at M.D. Anderson Cancer Center. The CML database updating the clinical and basic research investigations was reviewed as the source of this report. Publications resulting from these investigations were summarized. The long-term results with intensive chemotherapy, IFN-alpha therapy alone or in combination, autologous stem cell transplantation, and new agents such as homoharringtonine and decitabine showed encouraging results. Biological studies related to the BCR-ABL molecular abnormality, other molecular events, and the detection of minimal residual disease were detailed. Future strategies with potential promise in CML were outlined. Significant progress in understanding CML biology and in treating patients afflicted with the disease has occurred. Several therapeutic and research tools are currently investigated, which should hopefully improve further the prognosis of patients with CML. (+info)American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. (3/1614)
OBJECTIVE: To determine an effective, evidence-based, postoperative surveillance strategy for the detection and treatment of recurrent breast cancer. Tests are recommended only if they have an impact on the outcomes specified by American Society of Clinical Oncology (ASCO) for clinical practice guidelines. POTENTIAL INTERVENTION: All tests described in the literature for postoperative monitoring were considered. In addition, the data were critically evaluated to determine the optimal frequency of monitoring. OUTCOME: Outcomes of interest include overall and disease-free survival, quality of life, toxicity reduction, and secondarily cost-effectiveness. EVIDENCE: A search was performed to determine all relevant articles published over the past 20 years on the efficacy of surveillance testing for breast cancer recurrence. These publications comprised both retrospective and prospective studies. VALUES: Levels of evidence and guideline grades were rated by a standard process. More weight was given to studies that tested a hypothesis directly relating testing to one of the primary outcomes in a randomized design. BENEFITS, HARMS, AND COSTS: The possible consequences of false-positive and -negative tests were considered in evaluating a preference for one of two tests providing similar information. Cost alone was not a determining factor. RECOMMENDATIONS: The attached guidelines and text summarize the updated recommendations of the ASCO breast cancer expert panel. Data are sufficient to recommend monthly breast self-examination, annual mammography of the preserved and contralateral breast, and a careful history and physical examination every 3 to 6 months for 3 years, then every 6 to 12 months for 2 years, then annually. Data are not sufficient to recommend routine bone scans, chest radiographs, hematologic blood counts, tumor markers (carcinoembryonic antigen, cancer antigen [CA] 15-5, and CA 27.29), liver ultrasonograms, or computed tomography scans. VALIDATION: The recommendations of the breast cancer expert panel were evaluated and supported by the ASCO Health Services Research Committee reviewers and the ASCO Board of Directors. (+info)Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation. (4/1614)
A randomized controlled trial (RCT) comparing primary-care-centred follow-up of breast cancer patients with the current standard practice of specialist-centred follow-up showed no increase in delay in diagnosing recurrence, and no increase in anxiety or deterioration in health-related quality of life. An economic evaluation of the two schemes of follow-up was conducted concurrent with the RCT Because the RCT found no difference in the primary clinical outcomes, a cost minimization analysis was conducted. Process measures of the quality of care such as frequency and length of visits were superior in primary care. Costs to patients and to the health service were lower in primary care. There was no difference in total costs of diagnostic tests, with particular tests being performed more frequently in primary care than in specialist care. Data are provided on the average frequency and length of visits, and frequency of diagnostic testing for breast cancer patients during the follow-up period. (+info)Cancer carve outs, specialty networks, and disease management: a review of their evolution, effectiveness, and prognosis. (5/1614)
Specialty care programs for patients with cancer were among the first to be developed, yet they have been some of the slowest to grow or to demonstrate success. This paper reviews the evolution of cancer carve outs, disease management, and specialty networks by distinguishing purchasers from sellers on key attributes. It also describes financing and operational impediments to their growth and summarizes what little published data there is documenting the success of these programs. The paper analyzes the critical factors impeding the development of these cancer programs, and discusses the public policy changes and health services research that will need to be conducted before the performance and market influence of cancer carve outs will reach their full potential. (+info)Audiotapes and letters to patients: the practice and views of oncologists, surgeons and general practitioners. (6/1614)
A range of measures have been proposed to enhance the provision of information to cancer patients and randomized controlled trials have demonstrated their impact on patient satisfaction and recall. The current study explored the practice and views of oncologists, surgeons and general practitioners (GPs) with regards to providing patients with consultation audiotapes and summary letters. In stage 1, 28 semi-structured interviews with doctors were conducted to provide qualitative data on which to base a questionnaire. In stage 2, 113 medical oncologists, 43 radiation oncologists, 55 surgeons and 108 GPs completed questionnaires. Only one-third of doctors had ever provided patients with a copy of the letter written to the oncologist or referring doctor, and one-quarter had provided a summary letter or tape. The majority of doctors were opposed to such measures; however, a substantial minority were in favour of providing a letter or tape under certain conditions. More surgeons and GPs (> two-thirds) were opposed to specialists providing a consultation audiotape than oncologists (one-third). Gender, years of experience and attitude to patient involvement in decision-making were predictive of doctors' attitudes. The majority of doctors remain opposed to offering patients personalized information aids. However, practice and perspectives appear to be changing. (+info)Systematic review of cancer treatment programmes in remote and rural areas. (7/1614)
In an attempt to ensure high quality cancer treatment for all patients in the UK, care is being centralized in specialist centres and units. For patients in outlying areas, however, access problems may adversely affect treatment. In an attempt to assess alternative methods of delivering cancer care, this paper reviews published evidence about programmes that have set out to provide oncology services in remote and rural areas in order to identify evidence of effectiveness and problems. Keyword and textword searches of on-line databases (MEDLINE, EMBASE, HEALTHSTAR and CINAHL) from 1978 to 1997 and manual searches of references were conducted. Fifteen papers reported evaluations of oncology outreach programmes, tele-oncology programmes and rural hospital initiatives. All studies were small and only two were controlled, so evidence was suggestive rather than conclusive. There were some indications that shared outreach care was safe and could make specialist care more accessible to outlying patients. Tele-oncology, by which some consultations are conducted using televideo, may be an acceptable adjunct. Larger and more methodologically robust studies are justified and should be conducted. (+info)Improving the letters we write: an exploration of doctor-doctor communication in cancer care. (8/1614)
Referral and reply letters are common means by which doctors exchange information pertinent to patient care. Twenty-eight semi-structured interviews were conducted exploring the views of oncologists, referring surgeons and general practitioners. Twenty-seven categories of information in referral letters and 32 in reply letters after a consultation were defined. The letters to and from six medical oncologists relating to 20 consecutive new patients were copied, and their content analysed. Oncologists, surgeons and general practitioners Australia wide were surveyed using questionnaires developed on data obtained above. Only four of 27 categories of referral information appear regularly (in > 50%) in referral letters. Oncologists want most to receive information regarding the patient's medical status, the involvement of other doctors, and any special considerations. Referring surgeons and family doctors identified delay in receiving the consultant's reply letter as of greatest concern, and insufficient detail as relatively common problems. Reply letters include more information regarding patient history/background than the recipients would like. Referring surgeons and family doctors want information regarding the proposed treatment, expected outcomes, and any psychosocial concerns, yet these items are often omitted. Consultants and referring doctors need to review, and modify their letter writing practices. (+info)Medical oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer using systemic medications, including chemotherapy, hormonal therapy, targeted therapy, and immunotherapy. Medical oncologists are specialized physicians who manage cancer patients throughout their illness, from diagnosis to survivorship or end-of-life care. They work closely with other healthcare professionals, such as surgeons, radiation oncologists, radiologists, pathologists, and nurses, to provide comprehensive cancer care for their patients. The primary goal of medical oncology is to improve the quality of life and overall survival of cancer patients while minimizing side effects and toxicities associated with cancer treatments.
Neoplasms are abnormal growths of cells or tissues in the body that serve no physiological function. They can be benign (non-cancerous) or malignant (cancerous). Benign neoplasms are typically slow growing and do not spread to other parts of the body, while malignant neoplasms are aggressive, invasive, and can metastasize to distant sites.
Neoplasms occur when there is a dysregulation in the normal process of cell division and differentiation, leading to uncontrolled growth and accumulation of cells. This can result from genetic mutations or other factors such as viral infections, environmental exposures, or hormonal imbalances.
Neoplasms can develop in any organ or tissue of the body and can cause various symptoms depending on their size, location, and type. Treatment options for neoplasms include surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy, among others.
Hematology is a branch of medicine that deals with the study of blood, its physiology, and pathophysiology. It involves the diagnosis, treatment, and prevention of diseases related to the blood and blood-forming organs such as the bone marrow, spleen, and lymphatic system. This includes disorders of red and white blood cells, platelets, hemoglobin, blood vessels, and coagulation (blood clotting). Some common hematological diseases include anemia, leukemia, lymphoma, sickle cell disease, and bleeding disorders like hemophilia.
Cancer care facilities are healthcare institutions that provide medical and supportive services to patients diagnosed with cancer. These facilities offer a range of treatments, including surgery, radiation therapy, chemotherapy, immunotherapy, and hormone therapy. They also provide diagnostic services, pain management, rehabilitation, palliative care, and psychosocial support to help patients cope with the physical and emotional challenges of cancer and its treatment.
Cancer care facilities can vary in size and scope, from large academic medical centers that offer cutting-edge clinical trials and specialized treatments, to community hospitals and outpatient clinics that provide more routine cancer care. Some cancer care facilities specialize in specific types of cancer or treatments, while others offer a comprehensive range of services for all types of cancer.
In addition to medical treatment, cancer care facilities may also provide complementary therapies such as acupuncture, massage, and yoga to help patients manage symptoms and improve their quality of life during and after treatment. They may also offer support groups, counseling, and other resources to help patients and their families cope with the challenges of cancer.
Overall, cancer care facilities play a critical role in diagnosing, treating, and supporting patients with cancer, helping them to achieve the best possible outcomes and quality of life.
Medical societies are professional organizations composed of physicians, surgeons, and other healthcare professionals who share a common purpose of promoting medical research, education, and patient care. These societies can focus on specific medical specialties, such as the American Society of Clinical Oncology (ASCO) for cancer specialists or the American College of Surgeons (ACS) for surgeons. They may also address broader issues related to healthcare policy, advocacy, and ethics. Medical societies often provide resources for continuing medical education, publish scientific journals, establish clinical practice guidelines, and offer networking opportunities for members.
Palliative care is a type of medical care that focuses on relieving the pain, symptoms, and stress of serious illnesses. The goal is to improve quality of life for both the patient and their family. It is provided by a team of doctors, nurses, and other specialists who work together to address the physical, emotional, social, and spiritual needs of the patient. Palliative care can be provided at any stage of an illness, alongside curative treatments, and is not dependent on prognosis.
The World Health Organization (WHO) defines palliative care as: "an approach that improves the quality of life of patients and their families facing the problems associated with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychological and spiritual."
Oncology nursing is a specialized area of nursing that focuses on the care of patients with cancer. Oncology nurses are responsible for providing comprehensive nursing care to patients throughout all stages of their illness, from diagnosis and treatment to recovery or palliative care. They work closely with other healthcare professionals, such as oncologists, radiotherapists, and social workers, to provide a coordinated approach to patient care.
Oncology nurses must have a deep understanding of the various types of cancer, their treatments, and the potential side effects of those treatments. They must also be skilled in assessing patients' physical and emotional needs, providing education and support to patients and their families, and managing symptoms such as pain, nausea, and fatigue.
In addition to direct patient care, oncology nurses may also be involved in research, advocacy, and education related to cancer and its treatment. They may work in a variety of settings, including hospitals, clinics, private practices, and long-term care facilities.
Radiation oncology is a branch of medicine that uses ionizing radiation in the treatment and management of cancer. The goal of radiation therapy, which is the primary treatment modality in radiation oncology, is to destroy cancer cells or inhibit their growth while minimizing damage to normal tissues. This is achieved through the use of high-energy radiation beams, such as X-rays, gamma rays, and charged particles, that are directed at the tumor site with precision. Radiation oncologists work in interdisciplinary teams with other healthcare professionals, including medical physicists, dosimetrists, and radiation therapists, to plan and deliver effective radiation treatments for cancer patients.
Antineoplastic agents are a class of drugs used to treat malignant neoplasms or cancer. These agents work by inhibiting the growth and proliferation of cancer cells, either by killing them or preventing their division and replication. Antineoplastic agents can be classified based on their mechanism of action, such as alkylating agents, antimetabolites, topoisomerase inhibitors, mitotic inhibitors, and targeted therapy agents.
Alkylating agents work by adding alkyl groups to DNA, which can cause cross-linking of DNA strands and ultimately lead to cell death. Antimetabolites interfere with the metabolic processes necessary for DNA synthesis and replication, while topoisomerase inhibitors prevent the relaxation of supercoiled DNA during replication. Mitotic inhibitors disrupt the normal functioning of the mitotic spindle, which is essential for cell division. Targeted therapy agents are designed to target specific molecular abnormalities in cancer cells, such as mutated oncogenes or dysregulated signaling pathways.
It's important to note that antineoplastic agents can also affect normal cells and tissues, leading to various side effects such as nausea, vomiting, hair loss, and myelosuppression (suppression of bone marrow function). Therefore, the use of these drugs requires careful monitoring and management of their potential adverse effects.
Clinical trials are research studies that involve human participants and are designed to evaluate the safety and efficacy of new medical treatments, drugs, devices, or behavioral interventions. The purpose of clinical trials is to determine whether a new intervention is safe, effective, and beneficial for patients, as well as to compare it with currently available treatments. Clinical trials follow a series of phases, each with specific goals and criteria, before a new intervention can be approved by regulatory authorities for widespread use.
Clinical trials are conducted according to a protocol, which is a detailed plan that outlines the study's objectives, design, methodology, statistical analysis, and ethical considerations. The protocol is developed and reviewed by a team of medical experts, statisticians, and ethicists, and it must be approved by an institutional review board (IRB) before the trial can begin.
Participation in clinical trials is voluntary, and participants must provide informed consent before enrolling in the study. Informed consent involves providing potential participants with detailed information about the study's purpose, procedures, risks, benefits, and alternatives, as well as their rights as research subjects. Participants can withdraw from the study at any time without penalty or loss of benefits to which they are entitled.
Clinical trials are essential for advancing medical knowledge and improving patient care. They help researchers identify new treatments, diagnostic tools, and prevention strategies that can benefit patients and improve public health. However, clinical trials also pose potential risks to participants, including adverse effects from experimental interventions, time commitment, and inconvenience. Therefore, it is important for researchers to carefully design and conduct clinical trials to minimize risks and ensure that the benefits outweigh the risks.
Antineoplastic combined chemotherapy protocols refer to a treatment plan for cancer that involves the use of more than one antineoplastic (chemotherapy) drug given in a specific sequence and schedule. The combination of drugs is used because they may work better together to destroy cancer cells compared to using a single agent alone. This approach can also help to reduce the likelihood of cancer cells becoming resistant to the treatment.
The choice of drugs, dose, duration, and frequency are determined by various factors such as the type and stage of cancer, patient's overall health, and potential side effects. Combination chemotherapy protocols can be used in various settings, including as a primary treatment, adjuvant therapy (given after surgery or radiation to kill any remaining cancer cells), neoadjuvant therapy (given before surgery or radiation to shrink the tumor), or palliative care (to alleviate symptoms and prolong survival).
It is important to note that while combined chemotherapy protocols can be effective in treating certain types of cancer, they can also cause significant side effects, including nausea, vomiting, hair loss, fatigue, and an increased risk of infection. Therefore, patients undergoing such treatment should be closely monitored and managed by a healthcare team experienced in administering chemotherapy.
I'm sorry for any confusion, but "Italy" is not a medical term or concept. It is a country located in Southern Europe. If you have any questions related to medical terminology or health-related topics, I would be happy to try and help answer those for you.
An Oncology Service in a hospital refers to the specialized department or unit that provides comprehensive cancer care and treatment. It is typically staffed with various healthcare professionals such as medical oncologists, radiation oncologists, surgical oncologists, oncology nurses, radiologists, pathologists, social workers, and psychologists who work together to provide a multidisciplinary approach to cancer diagnosis, treatment, and follow-up care.
The oncology service may offer various treatments such as chemotherapy, radiation therapy, immunotherapy, hormone therapy, and surgery, depending on the type and stage of cancer. They also provide supportive care services like pain management, nutritional support, and rehabilitation to help patients manage symptoms and improve their quality of life during and after treatment.
Overall, an Oncology Service in a hospital is dedicated to providing compassionate and evidence-based cancer care to patients and their families throughout the entire cancer journey.
Adjuvant chemotherapy is a medical treatment that is given in addition to the primary therapy, such as surgery or radiation, to increase the chances of a cure or to reduce the risk of recurrence in patients with cancer. It involves the use of chemicals (chemotherapeutic agents) to destroy any remaining cancer cells that may not have been removed by the primary treatment. This type of chemotherapy is typically given after the main treatment has been completed, and its goal is to kill any residual cancer cells that may be present in the body and reduce the risk of the cancer coming back. The specific drugs used and the duration of treatment will depend on the type and stage of cancer being treated.
Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.
Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.
Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.
Medical survival rate is a statistical measure used to determine the percentage of patients who are still alive for a specific period of time after their diagnosis or treatment for a certain condition or disease. It is often expressed as a five-year survival rate, which refers to the proportion of people who are alive five years after their diagnosis. Survival rates can be affected by many factors, including the stage of the disease at diagnosis, the patient's age and overall health, the effectiveness of treatment, and other health conditions that the patient may have. It is important to note that survival rates are statistical estimates and do not necessarily predict an individual patient's prognosis.
A questionnaire in the medical context is a standardized, systematic, and structured tool used to gather information from individuals regarding their symptoms, medical history, lifestyle, or other health-related factors. It typically consists of a series of written questions that can be either self-administered or administered by an interviewer. Questionnaires are widely used in various areas of healthcare, including clinical research, epidemiological studies, patient care, and health services evaluation to collect data that can inform diagnosis, treatment planning, and population health management. They provide a consistent and organized method for obtaining information from large groups or individual patients, helping to ensure accurate and comprehensive data collection while minimizing bias and variability in the information gathered.
Neoplasm staging is a systematic process used in medicine to describe the extent of spread of a cancer, including the size and location of the original (primary) tumor and whether it has metastasized (spread) to other parts of the body. The most widely accepted system for this purpose is the TNM classification system developed by the American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC).
In this system, T stands for tumor, and it describes the size and extent of the primary tumor. N stands for nodes, and it indicates whether the cancer has spread to nearby lymph nodes. M stands for metastasis, and it shows whether the cancer has spread to distant parts of the body.
Each letter is followed by a number that provides more details about the extent of the disease. For example, a T1N0M0 cancer means that the primary tumor is small and has not spread to nearby lymph nodes or distant sites. The higher the numbers, the more advanced the cancer.
Staging helps doctors determine the most appropriate treatment for each patient and estimate the patient's prognosis. It is an essential tool for communication among members of the healthcare team and for comparing outcomes of treatments in clinical trials.
Lung neoplasms refer to abnormal growths or tumors in the lung tissue. These tumors can be benign (non-cancerous) or malignant (cancerous). Malignant lung neoplasms are further classified into two main types: small cell lung carcinoma and non-small cell lung carcinoma. Lung neoplasms can cause symptoms such as cough, chest pain, shortness of breath, and weight loss. They are often caused by smoking or exposure to secondhand smoke, but can also occur due to genetic factors, radiation exposure, and other environmental carcinogens. Early detection and treatment of lung neoplasms is crucial for improving outcomes and survival rates.
I'm sorry for any confusion, but "United States" is a geopolitical entity, specifically the name of the country consisting of 50 states, and it is not a medical term or concept. Therefore, I can't provide a medical definition for it. If you have any questions related to health, medicine, or biology, I would be happy to try to help answer those!
Breast neoplasms refer to abnormal growths in the breast tissue that can be benign or malignant. Benign breast neoplasms are non-cancerous tumors or growths, while malignant breast neoplasms are cancerous tumors that can invade surrounding tissues and spread to other parts of the body.
Breast neoplasms can arise from different types of cells in the breast, including milk ducts, milk sacs (lobules), or connective tissue. The most common type of breast cancer is ductal carcinoma, which starts in the milk ducts and can spread to other parts of the breast and nearby structures.
Breast neoplasms are usually detected through screening methods such as mammography, ultrasound, or MRI, or through self-examination or clinical examination. Treatment options for breast neoplasms depend on several factors, including the type and stage of the tumor, the patient's age and overall health, and personal preferences. Treatment may include surgery, radiation therapy, chemotherapy, hormone therapy, or targeted therapy.
Prognosis is a medical term that refers to the prediction of the likely outcome or course of a disease, including the chances of recovery or recurrence, based on the patient's symptoms, medical history, physical examination, and diagnostic tests. It is an important aspect of clinical decision-making and patient communication, as it helps doctors and patients make informed decisions about treatment options, set realistic expectations, and plan for future care.
Prognosis can be expressed in various ways, such as percentages, categories (e.g., good, fair, poor), or survival rates, depending on the nature of the disease and the available evidence. However, it is important to note that prognosis is not an exact science and may vary depending on individual factors, such as age, overall health status, and response to treatment. Therefore, it should be used as a guide rather than a definitive forecast.
Colorectal neoplasms refer to abnormal growths in the colon or rectum, which can be benign or malignant. These growths can arise from the inner lining (mucosa) of the colon or rectum and can take various forms such as polyps, adenomas, or carcinomas.
Benign neoplasms, such as hyperplastic polyps and inflammatory polyps, are not cancerous but may need to be removed to prevent the development of malignant tumors. Adenomas, on the other hand, are precancerous lesions that can develop into colorectal cancer if left untreated.
Colorectal cancer is a malignant neoplasm that arises from the uncontrolled growth and division of cells in the colon or rectum. It is one of the most common types of cancer worldwide and can spread to other parts of the body through the bloodstream or lymphatic system.
Regular screening for colorectal neoplasms is recommended for individuals over the age of 50, as early detection and removal of precancerous lesions can significantly reduce the risk of developing colorectal cancer.
European Society for Medical Oncology
Journal of Medical Imaging and Radiation Oncology
Indian Journal of Medical and Paediatric Oncology
List of members of the National Academy of Sciences (Medical genetics, hematology, and oncology)
Warburg effect (oncology)
Gynecologic oncology
Oncology
Oxford Institute for Radiation Oncology
European School of Oncology
Clinical Oncology
Current Oncology
Annals of Oncology
Abeloff's Clinical Oncology
Oncology Letters
Radiotherapy & Oncology (journal)
Oncology Care Model
Gynecologic Oncology (journal)
Society of Gynecologic Oncology
Journal of Surgical Oncology
JAMA Oncology
Oncology Reports
Neuro-Oncology (journal)
Molecular Oncology (journal)
Japanese Journal of Clinical Oncology
Future Oncology
Journal of Cancer Research and Clinical Oncology
Index of oncology articles
International Journal of Oncology
Journal of Neuro-Oncology
Oncology information system
European Society for Medical Oncology2
- The European Society for Medical Oncology (ESMO) is the leading professional organisation for medical oncology. (wikipedia.org)
- Miembro de ESMO (European Society For Medical Oncology). (cun.es)
Pediatric oncology6
- Founded in 1990, ESMO's flagship scientific journal, Annals of Oncology, publishes articles addressing medical oncology, surgery, radiotherapy, pediatric oncology, basic research and the comprehensive management of patients with malignant diseases. (wikipedia.org)
- Materials and Methods A retrospective analysis was performed on patients (≤ 14 years) with cancer attending the pediatric oncology services of our institute who tested positive for the SARS-CoV-2 infection and those who had COVID-19 disease between August 2020 and May 2021. (thieme-connect.com)
- It was the pediatric oncology department. (lww.com)
- Medical cannabis in pediatric oncology: a survey of patients and caregivers. (bvsalud.org)
- There are minimal data regarding the safety and efficacy of cannabis used as an anti- cancer agent or for symptom management in pediatric oncology. (bvsalud.org)
- An anonymous 40 question paper survey was offered to patients / caregivers of children with cancer attending a pediatric oncology clinic in a provincially mandated cancer agency between October 2019 and March 2020. (bvsalud.org)
Hematology and Oncology3
- The MSL will disseminate clinical information about Gilead's innovative hematology and oncology products to key opinion leaders, academic institutions, community group practices, healthcare professionals (including allied healthcare members), and professional organizations. (biospace.com)
- Dr. Alva B. Weir III, MD , Professor of Medicine UTHSC and Section Chief of Hematology Oncology at VAMC, is the program director of the UTHSC Hematology and Oncology Division Fellowship Program. (uthsc.edu)
- Provides a unique opportunity for physicians interested in academic careers to develop a strong clinical grounding in hematology and oncology as well as a comprehensive introduction to clinical, laboratory and translational-based research. (nih.gov)
Oncologists6
- These awards will provide the opportunity for recent, clinically trained underrepresented minority physicians and D.O.'s to gain sufficient research expertise to become medical oncologists with experience in biomedical research. (nih.gov)
- The Society provides fellowships for research training for young oncologists, an Exam in Medical Oncology and an accreditation program for institutes providing patients with integrated supportive and palliative care. (wikipedia.org)
- Our findings confirm that oncologists should consider inflammation and frailty in their patients, and perhaps personalize treatment, especially in older adults, to avoid undue risks of chemotherapy toxicity," said Nikesha Gilmore, Ph.D ., research assistant professor of Surgery at the University of Rochester Medical Center , who conducts studies for Wilmot's Cancer Prevention and Control program. (rochester.edu)
- They work closely with our surgeons, medical oncologists and primary care physicians to determine the best treatment plans for you. (providence.org)
- There are lots of oncologists, many of whom you don't really meet at medical school or even as a medical Senior House Doctor (SHO). (rcpe.ac.uk)
- Join us for our bi-monthly Medical Student Q&A where you will have the opportunity to meet faculty and resident radiation oncologists and ask any questions you have about how radiation is used to treat cancer, career paths within the specialty, research opportunities, the residency application process and tips for being a competitive applicant. (astro.org)
Geriatric Oncology Research Group1
- The Geriatric Oncology Research Group conducts studies that focus on the design and implementation of large, multi-site studies evaluating cancer care delivery methods, supportive care, aging biomarkers, and therapeutic interventions for older adults with cancer. (rochester.edu)
American Society for Radiation Oncology1
- Showcased for the first time at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Atlanta last month, RapidPlan opens the door to enhanced treatment planning by providing clinics with knowledge-based models that generate high-quality personalized treatment plans for their patients. (varian.com)
Patients11
- Medical students will work alongside clinical staff and follow patients in the out-patient clinics as well as the wards. (nih.gov)
- Time on the clinical service is characterized by exposure to a broad range of complex pathology, emphasizing multidisciplinary care of oncology patients. (nih.gov)
- Fellows provide clinical care for patients enrolled on various clinical research protocols, both from within the Surgical Oncology Program and from across the NIH. (nih.gov)
- Boston Medical Center is committed to empowering all patients to thrive, through our innovative and equitable care. (bmc.org)
- At Boston Medical Center, research efforts are imperative in allowing us to provide our patients with quality care. (bmc.org)
- The oncology medical home improves the relationship between a patient and their care team, leading to higher quality care, lower costs and happier patients. (ncqa.org)
- Oncology practices have a unique relationship with patients: They provide the principal long-term care of patients in active cancer treatment, often taking on the role of primary care providers. (ncqa.org)
- The Oncology Medical Home is built off the PCSP standards-which emphasize team-based care, care coordination, care management and population health-and include oncology-specific elements designed to improve the care of patients with cancer. (ncqa.org)
- Additional services dedicated to our patients include nutrition, psychology, palliative care, radiation oncology and surgical oncology. (uthsc.edu)
- Most oncology patients are managed through multidisciplinary tumor conferences. (uthsc.edu)
- As a physician, I'm particularly excited about how we can 'train' the RapidPlan tool by using information from our best plans as a starting point when planning for new patients," says Dee Khuntia, Varian's vice president for medical affairs. (varian.com)
Specialty4
- Over the course of the fellowship, trainees will develop a solid basis for the conduct of clinical, translational, and laboratory research in oncology that lays the foundation for future specialty training and academic practice. (nih.gov)
- Oncology Medical Home Recognition evolved from NCQA's Patient-Centered Specialty Practice (PCSP) Recognition program, which helps facilitate team-based care by recognizing specialists who use the PCMH model to improve collaboration and health care delivery. (ncqa.org)
- The Medical Oncology curriculum is made up six Generic CiPs which are common to all physicianly specialties, seven Oncology CiPs shared with Clinical Oncology and five Specialty CiPs unique to Medical Oncology. (gmc-uk.org)
- medical oncology is an academic specialty focusing on drug development. (rcpe.ac.uk)
Radiotherapy and Oncology1
- Computers in radiotherapy and oncology : proceedings of the Workshop on the Use of Computers in Data Handling in Radiotherapy and Oncology in Europe held at the Headquarters of the World Health Organization, Geneva, 26-28 March 1984 / edited by R. F. Mould. (who.int)
Endocrine Surgery1
- Time is evenly split among the Surgical Oncology, Endocrine Surgery, and Thoracic Surgery services. (nih.gov)
Breast Surgical Oncology1
- Dr. O'Kelly is board certified in General Surgery and sub specializes in Breast Surgical Oncology. (dignityhealth.org)
Centers2
- Our award-winning and comprehensive medical centers include Providence St. Patrick Hospital in Missoula and Providence St. Joseph Medical Center, a critical access hospital in Polson. (campusrn.com)
- The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. (varian.com)
Annals of Oncology2
- Annals of Oncology is the official journal of ESMO and from 2008 of the Japanese Society for Medical Oncology (JSMO)[citation needed] The ESMO Clinical Practice Guidelines (CPG) are intended to provide oncology professionals with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine. (wikipedia.org)
- Annals of Oncology. (wikipedia.org)
ESMO2
- With more than 25,000 members representing oncology professionals from over 160 countries worldwide, ESMO was founded in 1975. (wikipedia.org)
- ESMO publishes handbooks, scientific meeting reports, and medical oncology training guidelines. (wikipedia.org)
Fellowship Program1
- The Surgical Oncology Research Fellowship Program at the National Cancer Institute (NCI) trains surgeons who are committed to academic careers in the expanding field of surgical oncology. (nih.gov)
Residency4
- This three-year residency program, which is accredited by CAMPEP , provides strong competency in clinical medical physics along with clinically oriented research and development experience. (hopkinsmedicine.org)
- The Medical Physics Residency Rotation Guide describes the program in detail. (hopkinsmedicine.org)
- She completed her residency in General Surgery at University of Washington and went on to do a subspecialty fellowship in Surgical Breast Oncology at the University of Southern California. (dignityhealth.org)
- After receiving her M.D.-Ph.D. from Washington University (St. Louis, Missouri), she did an internship at Presbyterian Hospital (Philadelphia), a residency in ophthalmology at the Scheie Eye Institute, University of Pennsylvania (Philadelphia), and a Medical Retina Clinical Fellowship at the National Eye Institute. (nih.gov)
Multidisciplinary3
- Each week, the Medical Oncology Service also organizes a number of departmental and multidisciplinary conferences, which students are expected to attend. (nih.gov)
- ESO, ESSO and ESTRO are pleased to announce the jointly organised multidisciplinary course in oncology for medical students. (eso.net)
- The multidisciplinary course in oncology will provide insight into all aspects of oncology with both theoretical and practical sessions. (eso.net)
Graduate Medical Education1
- Apply to this program through the NIH Graduate Medical Education Application System . (nih.gov)
Oncologist2
- A medical oncologist, a doctor who specializes in treating cancer with medicine, heads up your cancer team. (sutterhealth.org)
- Richard Zelkowitz practices as an Oncologist in Norwalk, CT.He graduated from New York Medical College. (wellness.com)
Specialists3
- The Sutter Health network includes more than 130 medical oncology experts who work together with other specialists to diagnose, evaluate and treat cancer. (sutterhealth.org)
- Compare Dr. Cuevo with our nearby Medical Oncology Specialists at Reston Hospital Center. (healthgrades.com)
- Specialists from all relevant medical departments collaborate to ensure the best possible treatment plan that is individually tailored to each patient. (dignityhealth.org)
Conferences1
- Find Oncology CME Medical Conferences 2022 Browse Upcoming Onsite/ Online Oncology CME Medical Conferences and Register Today. (pegasusdirectory.com)
Varian4
- PALO ALTO, Calif., Oct. 21, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a radiotherapy treatment planning tool designed to enhance quality, consistency, and efficiency in radiotherapy treatment planning. (varian.com)
- Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. (varian.com)
- Varian is a premier supplier of tubes, digital detectors, and image processing workstations for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications. (varian.com)
- Varian Medical Systems employs approximately 6350 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. (varian.com)
Cancer16
- Medical marijuana may have a potential role in oncology for treating anticipatory and refractory chemotherapy-induced nausea and vomiting, for treating refractory cancer pain, and as an antitumor agent, a new review concludes. (medscape.com)
- Because of lack of evidence, the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology currently do not recommend marijuana for the treatment of chemotherapy-induced nausea and vomiting. (medscape.com)
- Full Text PAR-97-031 MINORITIES IN MEDICAL ONCOLOGY NIH GUIDE, Volume 26, Number 3, January 31, 1997 PA NUMBER: PAR-97-031 P.T. 34, FF Keywords: Oncology Cancer/Carcinogenesis National Cancer Institute Application Receipt Dates: June 1, October 1 and February 1 PURPOSE The Comprehensive Minority Biomedical Program, Division of Extramural Activities, National Cancer Institute announces the availability of minority medical oncology awards. (nih.gov)
- This Program Announcement (PA) for Minorities in Medical Oncology, is related to the priority area of cancer. (nih.gov)
- Eligible institutions must also have active biomedical research programs in oncology including clinical trials with adequate numbers of highly trained faculty in the clinical and biomedical sciences areas as they relate to cancer. (nih.gov)
- But medical oncology-the use of medicines to treat cancer-now offers new, precise and personalized treatments, including immunotherapy and targeted therapy, helping your chances for a successful outcome. (sutterhealth.org)
- Pancreatic oncology focuses on the management and treatment of pancreatic cancer through chemotherapy, radiation, surgery, and targeted cancer therapy. (healthgrades.com)
- Renal oncology focuses on the management and treatment of kidney cancer through surgery, immunotherapy, targeted therapy, radiation, and chemotherapy. (healthgrades.com)
- Children who undergo radiation treatment receive their care at the Comprehensive Cancer Center on the Legacy Good Samaritan Medical Center campus. (legacyhealth.org)
- Legacy Medical Group-Radiation Oncology is part of Legacy Cancer Institute , ranked as one of the nation's best cancer programs. (legacyhealth.org)
- The Hematology/Medical Oncology Service includes four Hematology/Oncology faculty, a nurse practitioner, oncology pharmacist, two cancer care coordinators and four nurses dedicated to chemotherapy administration. (uthsc.edu)
- Medical oncology is where cancer care meets academia and novel drug development through clinical trials. (rcpe.ac.uk)
- Texas Oncology-San Antonio Medical Center is how Texans fight cancer. (texasoncology.com)
- From diagnosis to treatment to survivorship, the oncology team at San Ramon Regional Medical Center is here to provide the best cancer treatment plan specifically for you. (sanramonmedctr.com)
- The National Cancer Institute/National Institutes of Health have provided this valuable resource ( Dictionary of Cancer Terms ) which allows you to search for cancer & medical-related terms and gives easy-to-understand definitions. (hoacny.com)
- and completed a fellowship in medical oncology at the Memorial Sloan-Kettering Cancer Center (New York). (nih.gov)
Radiation5
- The Medical Physics Adaptive Radiotherapy (MPART) Fellowship is a two-year education program offering clinical and research training to the next generation of post-graduate radiation therapy physicists to create and deliver personalized radiotherapy plans using advanced technologies in radiation oncology. (utsouthwestern.edu)
- Led by Bin Cai, Ph.D. , and overseen by MPART steering committee, the MPART Fellowship is administratively part of the Department of Radiation Oncology. (utsouthwestern.edu)
- Providence Radiation Oncology provides a range of world-class radiation therapies. (providence.org)
- If you experience pain during treatment, the radiation can be stopped so that the medical team can evaluate the situation and make adjustments if necessary. (providence.org)
- Are you a medical student looking to learn more about the field of radiation oncology? (astro.org)
Specialize2
- Physicians at Atlantic Surgical Oncology specialize in treating the following cancers and skin abnormalities. (atlantichealth.org)
- The key goal of this course is encouraging medical students to specialize in an oncology related discipline. (eso.net)
Treatments1
- Chemotherapy and other oncology treatments are usually delivered at one of Sutter's seven medical oncology clinics, staffed by certified oncology-trained nurses. (sutterhealth.org)
Research10
- They also call for more research in all areas related to medical marijuana use. (medscape.com)
- The purposes of these awards are to: o Encourage recently trained underrepresented minority clinicians to acquire research experience in medical oncology. (nih.gov)
- Candidates for the award should have broad clinical training, demonstrate individual competence in clinical activities, must document a serious intent for a research career in medical oncology, and must document a sensitivity to cultural issues impinging upon the practice of medicine among the major U.S. ethnic populations. (nih.gov)
- They must also demonstrate a commitment to the development of the research careers of young minority physicians in medical oncology. (nih.gov)
- The Medical Oncology Service and its affiliates conduct translational and clinical research focused on the biology of various tumors and the development of new drugs for treatment. (nih.gov)
- To train physician-scientists in a laboratory-to-clinic translational research setting to promote the development of their expertise in medical oncology research and to support their board certification by the American Board of Internal Medicine . (nih.gov)
- Our contributions to medical research and education lead to better healthcare outcomes. (sutterhealth.org)
- Project Wonder: the Art of Science at the Medical College of Wisconsin partners basic and translational scientists with local artists and writers to elevate and amplify their innovative, life-changing research. (mcw.edu)
- Gilead Sciences, Inc. is a research-based bio-pharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. (biospace.com)
- The Institute of Oncology and Hematology of Almazov Centre brings together research units carrying out fundamental and translational research in hematology, blood transfusion, rheumatology and infectious diseases. (almazovcentre.ru)
Practice1
- Oncology practice responsibilities. (ncqa.org)
Clinics2
- You should also bring any medical records you can provide, including slides or test results from other clinics. (uamshealth.com)
- Medical students and residents regularly rotate through clinics and consultation services. (uthsc.edu)
Physicians2
- BMC physicians are leaders in their fields with the most advanced medical technology at their fingertips and working alongside a highly skilled nursing and professional staff. (bmc.org)
- The team of physicians and medical staff takes care of the patient through all phases of care-from diagnosis to treatment to follow-up. (bmc.org)
Programme2
- In Medical Oncology, two years Internal Medicine Training will replace Core Medical Training as the core training programme. (gmc-uk.org)
- The programme incorporates plenary sessions, case study presentations, daily special visits to various oncology departments and group course projects that must be finalized and presented at the end of the course. (eso.net)
Postgraduate2
- Our standards for postgraduate medical curricula are Excellence by design and the framework for Generic professional capabilities . (gmc-uk.org)
- These help postgraduate medical training programmes focus trainee assessment away from an exhaustive list of individual competencies, towards fewer broad capabilities needed to practise safely from your first day as a consultant. (gmc-uk.org)
Search1
- Results of search for 'su:{Medical oncology. (who.int)
Specialist4
- Dr. Shailesh Patel, MD is a medical oncology specialist in Pensacola, FL. (healthgrades.com)
- Dr. Raymund Cuevo, MD is a medical oncology specialist in Fairfax, VA. He is affiliated with medical facilities such as Inova Loudoun Hospital and Inova Alexandria Hospital. (healthgrades.com)
- Medical Oncology Specialist. (cun.es)
- Graduated (1981) from the University of Cadiz, was awarded his doctorate (1985) in Medicine and Surgery from the University of Navarra and became a Medical Oncology Specialist (1991). (cun.es)
Center6
- Boston Medical Center (BMC) is a 514-bed academic medical center located in Boston's historic South End, providing medical care for infants, children, teens and adults. (bmc.org)
- These providers are on the medical staff of Reston Hospital Center. (healthgrades.com)
- UTHSC faculty members staff nearly all of Memphis VA Medical center. (uthsc.edu)
- From 1993-1995 he was a Fellow in the Department of Hematology-Oncology at the University of Nebraska Medical Center, Omaha (USA). (cun.es)
- Check back soon, the are no classes currently scheduled for San Ramon Regional Medical Center. (sanramonmedctr.com)
- See all of the upcoming classes and events sponsored by San Ramon Regional Medical Center. (sanramonmedctr.com)
Hospital1
- I had reluctantly appeared for the entrance examination for the D. M. Medical Oncology course at the Tata Memorial Hospital (TMH), Mumbai, as I felt that my preparation was not sufficient. (lww.com)
Program4
- Fellows will spend eighteen months most frequently in one of several laboratories within the Surgical Oncology Program- or the Thoracic Surgical Oncology Branch. (nih.gov)
- The program currently accepts graduates from CAMPEP-accredited medical physics programs. (hopkinsmedicine.org)
- WASHINGTON, DC -The National Committee for Quality Assurance (NCQA) launched a new Oncology Medical Home Recognition program, providing a framework for oncology practices to deliver care using the patient-centered medical home (PCMH) model. (ncqa.org)
- Our program is dedicated to sharing the latest medical science knowledge between disciplines in order to provide the best possible outcome for each patient. (dignityhealth.org)
Department2
- I walked into the outpatient consulting room of the head of the department (HOD) of medical oncology. (lww.com)
- In particular, the Department of Fundamental Oncology was established to study the biology of solid tumors and improve methods for their morphological, immunohistochemical and molecular genetic diagnosis. (almazovcentre.ru)
Hospitals1
- Applications may be submitted by domestic non-profit and for-profit organizations, public and private such as universities, colleges, hospitals, laboratories, units of State or local government, and eligible agencies of the Federal government or comparable institutions with well-established training programs in medical oncology. (nih.gov)
Patient care1
- The program's goal is to train highly competent medical physicists who will provide excellent patient care and will contribute as the next generation of leaders. (hopkinsmedicine.org)
Provide1
- For future appointments, please provide updated medical and insurance information. (uamshealth.com)
Departments1
- for the daily visits to various oncology departments a bus is foreseen. (eso.net)
Applicants1
- Applicants should have a recent PhD in medical physics, experimental physics, biophysics, or related discipline and have a demonstrated track record of experimental design and execution. (hopkinsmedicine.org)
Specialties1
- Choose from more than 140 specialties and sub-specialties for advanced medical training at MCW. (mcw.edu)
Care1
- Healthcare experts share forward-thinking views on the medical community's role in providing effective, authentic, and sustainable care. (bmc.org)
Cancers2
- The Medical Oncology Service has active programs for management of women's cancers (breast, ovarian and other gynecological malignancies), thoracic malignancies, genitourinary cancers, gastrointestinal cancers, and hematological malignancies such as lymphoma, and multiple myeloma and related precursor conditions. (nih.gov)
- There are more opportunities now to consider training in cancers traditionally associated with clinical oncology (i.e. radiotherapy-driven treatment), glioma or head and neck, for example. (rcpe.ac.uk)